Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-043979

General Counsel sold 1,420 shares at $9.65 ($13,710)

  • General Counsel acquired 3,924 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ring Christine General Counsel 2023-07-30 Option exercise +1,924 11,964 D
Ring Christine General Counsel 2023-07-30 Option exercise +2,000 13,964 D
Ring Christine General Counsel 2023-07-31 Sale −1,420 $9.65 $13,710 12,544 D
Derivatives
Ring Christine General Counsel 2023-07-30 Option exercise · Restricted Stock Units −1,924 19,241 D
Ring Christine General Counsel 2023-07-30 Option exercise · Restricted Stock Units −2,000 22,000 D
Open-market sales · 1,420 sh · avg $9.65 · $13,710
Loading xslF345X05/doc4.xml…